Why work with ImmunoDX?

                           ImmunoDX products are used world wide for research use. Learn more about our products!

Published articles

Divider
HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies.

HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies.

May 21, 2020Jawahar Raina

Abstract Broadly neutralizing antibodies (bNAbs) have been isolated from selected HIV-1-infected individuals and shown to bind to conserved sites on the envelope glycoprotein (Env). However, circulating plasma virus in these...

Read more
Pharmacological induction of CCL5 in vivo prevents gp120-mediated neuronal injury.

Pharmacological induction of CCL5 in vivo prevents gp120-mediated neuronal injury.

May 22, 2020Jawahar Raina

Abstract The human immunodeficiency virus (HIV) envelope protein gp120 promotes neuronal injury which is believed to cause HIV-associated neurocognitive disorders. Therefore, blocking the neurotoxic effect of gp120 may lead to...

Read more

Expression of CHRFAM7A and CHRNA7 in neuronal cells and post-mortem brain of HIV-infected patients: Considerations for HIV-Associated Neurocognitive Disorder

May 30, 2020Jawahar Raina

Products Related to Zika, WestNile, Dengue, Malaria, T.B, Chikungunya, HIV, SARS Product# 1039 HIV-1 YU2 (M Tropic)Envelope Glycoprotein gp41 Product# 1081 HIV-1 gp120 (ADA) Product# 1011 HIV-1 gp120 (subtype C) Product# 1031 HIV-1 gp120 (YU2)   Abstract Despite the recent advances in antiretroviral therapy, HIV-1 remains a global...

Read more

                                                                                        Our partners